BibTex RIS Cite

Karboksihemoglobin %65 Hasta Yaşar mı? Peki ya Sekel?

Year 2013, Volume: 4 Issue: 3, 112 - 114, 01.07.2013

Abstract

Karbon monoksit dünyada ölümle sonuçlanan zehirlenmelerin
yaklaşık yarısını oluşturmaktadır. Hücresel düzeyde toksisiteye neden olması ve oksijenin dokulara salınımını engellemesi zehirlenme etkilerini ortaya çıkarır. Karboksihemoglobin (COHb) düzeyi
ile klinik yansıma arasında literatürde net bilgi bulunmamaktadır.
Ancak düzeyin artışı mortalite ve morbidite için riski arttırmaktadır. Bu yazıda acil servise geliş COHb düzeyi %65 olan bir olgunun
takip süreci ile bu konuyu tekrar gözden geçirmeyi amaçladık.

References

  • Kao LW, Nanagas AK. Carbon monoxide poisoning. Emerg Med Clin North Am 2004; 22: 985-1018. [CrossRef]
  • Maloney G. Carbon monoxide. In Judith E. Tintinalli. MD, MS, Editor. Emer- gency Medicine. 7th ed. New York: McGraw Hill; 2011.p.1410-3.
  • Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poi- soning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985; 14: 1168-71. [CrossRef]
  • Hampson NB, Hauff NM. Risk factors for short-term mortality from car- bon monoxide poisoning treated with hyperbaric oxygen. Crit Care Med 2008; 36: 2523-7. [CrossRef]
  • Min SK. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand 1986; 73: 80-6. [CrossRef]
  • Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983; 40: 433-5. [CrossRef]
  • Olson KR. Carbon monoxide poisoning: mechanisms, presentation, and controversies in management. J Emerg Med 1984; 1: 233-43. [CrossRef]
  • Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimina- tion in man by high pressure oxygen. Science 1950; 111: 652-4. [CrossRef]
  • Scheinkestel CD, Bailey M, Myles PS, Jones K, Cooper DJ, Millar IL, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. MJA 1999; 170: 203-10.
  • Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2011; 4: CD002041.

Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?

Year 2013, Volume: 4 Issue: 3, 112 - 114, 01.07.2013

Abstract

Carbon monoxide is the reason for about half of fatal poisoning cases around the world. Carbon monoxide causes toxicity at the cellular level and the impedance in oxygen delivery to the tissues results in the effects of poisoning. There is no definitive information about a relationship between the level of carboxyhemoglobin (COHb) and clinical manifestations. However, an increase in the level of COHb increases the risk of mortality and morbidity. In this article, we will investigate the follow-up of a patient who presented to the emergency service with a 65% COHb level, in order to review the relationship between the level of carboxyhemoglobin (COHb) and clinical manifestations

References

  • Kao LW, Nanagas AK. Carbon monoxide poisoning. Emerg Med Clin North Am 2004; 22: 985-1018. [CrossRef]
  • Maloney G. Carbon monoxide. In Judith E. Tintinalli. MD, MS, Editor. Emer- gency Medicine. 7th ed. New York: McGraw Hill; 2011.p.1410-3.
  • Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poi- soning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985; 14: 1168-71. [CrossRef]
  • Hampson NB, Hauff NM. Risk factors for short-term mortality from car- bon monoxide poisoning treated with hyperbaric oxygen. Crit Care Med 2008; 36: 2523-7. [CrossRef]
  • Min SK. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand 1986; 73: 80-6. [CrossRef]
  • Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983; 40: 433-5. [CrossRef]
  • Olson KR. Carbon monoxide poisoning: mechanisms, presentation, and controversies in management. J Emerg Med 1984; 1: 233-43. [CrossRef]
  • Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimina- tion in man by high pressure oxygen. Science 1950; 111: 652-4. [CrossRef]
  • Scheinkestel CD, Bailey M, Myles PS, Jones K, Cooper DJ, Millar IL, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. MJA 1999; 170: 203-10.
  • Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2011; 4: CD002041.
There are 10 citations in total.

Details

Other ID JA35TV39UY
Journal Section Research Article
Authors

Filiz Baloğlu Kaya This is me

Şeyhmus Kaya This is me

Ahmet Tuğrul Zeytin This is me

Publication Date July 1, 2013
Submission Date July 1, 2013
Published in Issue Year 2013 Volume: 4 Issue: 3

Cite

APA Kaya, F. B., Kaya, Ş., & Zeytin, A. T. (2013). Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?. Journal of Emergency Medicine Case Reports, 4(3), 112-114.
AMA Kaya FB, Kaya Ş, Zeytin AT. Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?. Journal of Emergency Medicine Case Reports. July 2013;4(3):112-114.
Chicago Kaya, Filiz Baloğlu, Şeyhmus Kaya, and Ahmet Tuğrul Zeytin. “Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?”. Journal of Emergency Medicine Case Reports 4, no. 3 (July 2013): 112-14.
EndNote Kaya FB, Kaya Ş, Zeytin AT (July 1, 2013) Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?. Journal of Emergency Medicine Case Reports 4 3 112–114.
IEEE F. B. Kaya, Ş. Kaya, and A. T. Zeytin, “Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?”, Journal of Emergency Medicine Case Reports, vol. 4, no. 3, pp. 112–114, 2013.
ISNAD Kaya, Filiz Baloğlu et al. “Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?”. Journal of Emergency Medicine Case Reports 4/3 (July 2013), 112-114.
JAMA Kaya FB, Kaya Ş, Zeytin AT. Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?. Journal of Emergency Medicine Case Reports. 2013;4:112–114.
MLA Kaya, Filiz Baloğlu et al. “Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?”. Journal of Emergency Medicine Case Reports, vol. 4, no. 3, 2013, pp. 112-4.
Vancouver Kaya FB, Kaya Ş, Zeytin AT. Carboxyhemoglobin 65% Does the Patient Survive? What About Sequelae?. Journal of Emergency Medicine Case Reports. 2013;4(3):112-4.